There were days when I spent my entire time coughing, and because of bad cough I couldn’t sleep in the nights either. … There is some control still remaining in the fingers of my left hand thus allowing me to use my computer with the aid of a switch. … There is few more days of work remaining in the completion of my book, hopefully I will be done with it in the first week of January.
Read the full article →
A double-blinded, placebo-controlled, Phase 1, single ascending dose study was performed to assess the safety and tolerability of four single intravenous doses of NP001 in a total 32 individuals with ALS. … Importantly, following a single dose, there was a dose-dependent, statistically significant improvement in blood levels of the biomarker thought to be involved in ALS disease progression; this is a first in ALS. … Miller, M.D., the study’s principal investigator and Medical and Program Director of the Forbes Norris MDA/ALS Research Center, commented, “NP001 appears to have affected the level of a biomarker directly related to ALS pathogenesis in a dose-dependent manner.
Read the full article →